Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast

FEMS Yeast Research

Volumn 10, Issue 8, 2010, Pages 992-1005

  Vanhelmont, Thomas ^a   Vandebroek, Tom ^a   De Vos, Ann ^a   Terwel, Dick ^a   Lemaire, Katleen ^a   Anandhakumar, Jayamani ^a   Franssens, Vanessa ^a   Swinnen, Erwin ^a   Van Leuven, Fred ^a   Winderickx, Joris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aggregation; FTDP 17; Oxidative stress; Phosphorylation; Tau; Yeast

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; SERINE 409; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; FRONTOTEMPORAL DEMENTIA; MICROTUBULE; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE; WILD TYPE; YEAST CELL;

AMINO ACID SUBSTITUTION; HUMANS; MUTANT PROTEINS; MUTATION, MISSENSE; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN DENATURATION; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SERINE; TAU PROTEINS;

EID: 78349245542     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2010.00662.x     Document Type: Article

References (76)

1. Alonso Adel C, Li B, Grundke-Iqbal I & Iqbal K (2006) Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. P Natl Acad Sci USA 103: 8864-8869.
2. Augustinack JC, Schneider A, Mandelkow EM & Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103: 26-35.
3. Avila J, Dominguez J & Diaz-Nido J (1994) Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. Int J Dev Biol 38: 13-25.
4. Barghorn S & Mandelkow E (2002) Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41: 14885-14896.
5. Bunker JM, Kamath K, Wilson L, Jordan MA & Feinstein SC (2006) FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells. J Biol Chem 281: 11856-11863.
6. Castellani RJ, Nunomura A, Lee HG, Perry G & Smith MA (2008) Phosphorylated tau: toxic, protective, or none of the above. J Alzheimers Dis 14: 377-383.
7. Chang E, Kim S, Yin H, Nagaraja HN & Kuret J (2008) Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps. J Neurochem 107: 1113-1123.
8. Connell JW, Gibb GM, Betts JC et al. (2001) Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS Lett 493: 40-44.
9. Delobel P, Flament S, Hamdane M et al. (2002) Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. J Biol Chem 277: 9199-9205.
10. DeTure M, Ko LW, Easson C & Yen SH (2002) Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am J Pathol 161: 1711-1722.
11. Dickey CA, Kamal A, Lundgren K et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117: 648-658.
12. Drewes G (2004) MARKing tau for tangles and toxicity. Trends Biochem Sci 29: 548-555.
13. Ferrer I, Blanco R, Carmona M & Puig B (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J Neural Transm 108: 1397-1415.
14. Galas MC, Dourlen P, Begard S, Ando K, Blum D, Hamdane M & Buee L (2006) The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem 281: 19296-19304.
15. Gendron TF & Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4: 13.
16. Gietz D, St Jean A, Woods RA & Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20: 1425.
17. Götz J, Gladbach A, Pennanen L, Van Eersel J, Schild A, David D & Ittner LM (2009) Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta, DOI: DOI: 10.1016/j.bbadis.2009.09.008.
18. Gupta ML Jr, Bode CJ, Georg GI & Himes RH (2003) Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin. P Natl Acad Sci USA 100: 6394-6397.
19. Hallows JL, Chen K, DePinho RA & Vincent I (2003) Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J Neurosci 23: 10633-10644.
20. Han D, Qureshi HY, Lu Y & Paudel HK (2009) Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro. J Biol Chem 284: 13422-13433.
21. Iqbal K, Liu F, Gong CX, Alonso AC & Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69.
22. Jaworski T, Dewachter I, Seymour C-M, Borghgraef P, Devijver H, Kuegler S & Van Leuven F (2010) Alzheimer's disease: old problem, new views from transgenic and viral models. Biochim Biophys Acta, DOI: DOI: 10.1016/j.bbadis.2010.1003.1005.
23. Jeganathan S, Von Bergen M, Brutlach H, Steinhoff HJ & Mandelkow E (2006) Global hairpin folding of tau in solution. Biochemistry 45: 2283-2293.
24. Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM & Mandelkow E (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J Biol Chem 283: 32066-32076.
25. Jicha GA, Bowser R, Kazam IG & Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48: 128-132.
26. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J & Davies P (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci 19: 7486-7494.
27. Kaeberlein M, Burtner CR & Kennedy BK (2007) Recent developments in yeast aging. PLoS Genet 3: e84.
28. Kar S, Fan J, Smith MJ, Goedert M & Amos LA (2003) Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J 22: 70-77.
29. Kimura T, Ono T, Takamatsu J et al. (1996) Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 7: 177-181.
30. Landino LM, Skreslet TE & Alston JA (2004) Cysteine oxidation of tau and microtubule-associated protein-2 by peroxynitrite: modulation of microtubule assembly kinetics by the thioredoxin reductase system. J Biol Chem 279: 35101-35105.
31. Laun P, Pichova A, Madeo F et al. (2001) Aged mother cells of Saccharomyces cerevisiae show markers of oxidative stress and apoptosis. Mol Microbiol 39: 1166-1173.
32. Li T & Paudel HK (2006) Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45: 3125-3133.
33. LoPresti P & Konat GW (2001) Hydrogen peroxide induces transient dephosphorylation of tau protein in cultured rat oligodendrocytes. Neurosci Lett 311: 142-144.
34. Lu KP, Hanes SD & Hunter T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547.
35. Makrides V, Shen TE, Bhatia R, Smith BL, Thimm J, Lal R & Feinstein SC (2003) Microtubule-dependent oligomerization of tau. Implications for physiological tau function and tauopathies. J Biol Chem 278: 33298-33304.
36. Mancuso M, Coppede F, Murri L & Siciliano G (2007) Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? Antioxid Redox Sign 9: 1631-1646.
37. Mandelkow EM & Mandelkow E (1998) Tau in Alzheimer's disease. Trends Cell Biol 8: 425-427.
38. Mandelkow EM, Stamer K, Vogel R, Thies E & Mandelkow E (2003) Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24: 1079-1085.
39. Martinez A, Portero-Otin M, Pamplona R & Ferrer I (2009) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20: 281-297.
40. Matsumura N, Yamazaki T & Ihara Y (1999) Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am J Pathol 154: 1649-1656.
41. Melov S, Adlard PA, Morten K et al. (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2: e536.
42. Moreira PI, Santos MS, Oliveira CR et al. (2008) Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7: 3-10.
43. Perez M, Lim F, Arrasate M & Avila J (2000) The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J Neurochem 74: 2583-2589.
44. Perry G, Nunomura A, Hirai K et al. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Bio Med 33: 1475-1479.
45. Plattner F, Angelo M & Giese KP (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281: 25457-25465.
46. Poppek D, Keck S, Ermak G et al. (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400: 511-520.
47. Rademakers R, Cruts M & Van Broeckhoven C (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 24: 277-295.
48. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR & Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74: 1587-1595.
49. Reynolds MR, Berry RW & Binder LI (2007) Nitration in neurodegeneration: deciphering the 'Hows''nYs'. Biochemistry 46: 7325-7336.
50. Sahara N, Maeda S & Takashima A (2008) Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. Curr Alzheimer Res 5: 591-598.
51. Sakaue F, Saito T, Sato Y, Asada A, Ishiguro K, Hasegawa M & Hisanaga S (2005) Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J Biol Chem 280: 31522-31529.
52. Santacruz K, Lewis J, Spires T et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476-481.
53. Schweers O, Mandelkow EM, Biernat J & Mandelkow E (1995) Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. P Natl Acad Sci USA 92: 8463-8467.
54. Sergeant N, Bretteville A, Hamdane M et al. (2008) Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomic 5: 207-224.
55. Spillantini MG, Crowther RA, Kamphorst W, Heutink P & Van Swieten JC (1998) Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 153: 1359-1363.
56. Spillantini MG, Van Swieten JC & Goedert M (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2: 193-205.
57. 2 and Fenton reagents. Free Radical Res 35: 643-653.
58. Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA & Zhu X (2010) Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett 468: 267-271.
59. Takeda A, Smith MA, Avila J et al. (2000) In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 75: 1234-1241.
60. Tan YS, Morcos PA & Cannon JF (2003) Pho85 phosphorylates the Glc7 protein phosphatase regulator Glc8 in vivo. J Biol Chem 278: 147-153.
61. Tanaka K, Nakafuku M, Satoh T et al. (1990) S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell 60: 803-807.
62. Tatebayashi Y, Planel E, Chui DH et al. (2006) c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis. FASEB J 20: 762-764.
63. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H & Van Leuven F (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172: 786-798.
64. Towbin H, Staehelin T & Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. P Natl Acad Sci USA 76: 4350-4354.
65. Tremblay MA, Acker CM & Davies P (2009) Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. J Alzheimers Dis 19: 721-733.
66. Vandebroek T, Vanhelmont T, Terwel D et al. (2005) Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast. Biochemistry 44: 11466-11475.
67. Vandebroek T, Terwel D, Vanhelmont T et al. (2006) Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5. J Biol Chem 281: 25388-25397.
68. Van Dyck E, Foury F, Stillman B & Brill SJ (1992) A single-stranded DNA binding protein required for mitochondrial DNA replication in S. cerevisiae is homologous to E. coli SSB. EMBO J 11: 3421-3430.
69. Van Loon AP, Pesold-Hurt B & Schatz G (1986) A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. P Natl Acad Sci USA 83: 3820-3824.
70. Van Swieten JC, Stevens M, Rosso SM et al. (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 46: 617-626.
71. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ & Lee VM (2000) Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 11: 4093-4104.
72. Wach A, Brachat A, Pohlmann R & Philippsen P (1994) New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10: 1793-1808.
73. Wang Y, Martinez-Vicente M, Kruger U et al. (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 18: 4153-4170.
74. Winzeler EA, Shoemaker DD, Astromoff A et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906.
75. Zambrano CA, Egana JT, Nunez MT, Maccioni RB & Gonzalez-Billault C (2004) Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1. Free Radical Bio Med 36: 1393-1402.
76. Zhang B, Higuchi M, Yoshiyama Y et al. (2004) Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J Neurosci 24: 4657-4667.